Dr. Hobbs, MD, is a hematologist-oncologist specializing in hematologic malignancies and leukemia. She is an Associate Professor of Medicine at Harvard Medical School and serves as Clinical Director of the Adult Leukemia Service at Massachusetts General Hospital and the Mass General Brigham Cancer Center. She is also a Clinical Investigator and Associate Physician in the Division of Hematology and Medical Oncology at Massachusetts General Hospital, where she leads the Myeloproliferative Neoplasms Clinical and Research Program. Her clinical focus includes myeloid malignancies, precision use of targeted and investigational therapies, and the integration of stem cell transplantation strategies into complex cancer care. Her research centers on clinical trials of novel targeted and combination therapies, translational studies in genomics and biomarkers for myeloid neoplasms, and the cardiovascular and immune complications of hematologic disease. She is also known for a patient-centered approach to personalized care and for providing bilingual care in English and Spanish. In addition to her clinical and research leadership, Dr. Hobbs contributes to national and international guideline development, serves as an expert educator and speaker in hematology, and works with advocacy organizations to expand education and access to clinical trials. She earned her medical degree from the Icahn School of Medicine at Mount Sinai, completed her internal medicine residency at Brigham and Women’s Hospital, and went on to fellowship training in Hematology and Medical Oncology at Memorial Sloan Kettering Cancer Center.
Associate Professor
Medical School
2004 – 2008
Residency
2008 – 2011
Fellowship
2011 – 2014